Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Key Statistics for Merkel Cell Carcinoma
Skin cancer is by far the most common type of cancer in the United States. Merkel cell carcinoma (MCC) is a type of skin cancer, but it's not common. About 3,000 people are diagnosed with Merkel cell carcinoma in the United States each year.
The number of people diagnosed with Merkel cell carcinoma each year has been rising quickly over the past few decades. This is in part because of an increased awareness of this cancer, but it might also be due to an increase in risk factors. For instance, people are living longer, and more people are living with weakened immune systems (from previous treatment for cancer or other medical conditions).
- Most Americans diagnosed with Merkel cell carcinoma are older than age 70.
- Men are more likely to have MCC than women.
- More than 9 out of 10 Americans diagnosed with Merkel cell carcinoma are White people.
For survival statistics, see Survival Rates for Merkel Cell Carcinoma.
Visit the American Cancer Society’s Cancer Statistics Center for more key statistics.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
National Cancer Institute. Merkel Cell Carcinoma Treatment (PDQ)–Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/skin/hp/merkel-cell-treatment-pdq on May 28, 2024.
Paulson KG, Park SY, Vandeven NA, Lachance K, et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78(3):457.
Tai P, Nghiem PT, Park SY. Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-merkel-cell-neuroendocrine-carcinoma on November 18, 2024.
Last Revised: January 10, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.